Malaria vaccines market to surge past $ 591.8 million by 2024

2017-04-24 09:49:13

According to a report on the Global Malaria Vaccines Market published by Coherent Market Insights, the market is pegged to be valued at $8.5 million in 2018 and is projected to expand at a CAGR of 102.8% during the forecast period (2018-2024)By Team ABLEAccording to the report “Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine

Read more

Narayana Hrudayalaya to buy Panacea Biotec’s NewRise Healthcare for Rs180 crore

2017-04-24 09:31:51

According to Narayana Hrudayalaya’s BSE filing the hospital has acquired Gurgaon-based multi-speciality hospital NewRise Healthcare from Panacea Biotech Ltd for Rs 180 crore.By Team ABLEDevi Prasad Shetty-founded hospital chain, Narayana Hrudayalaya has entered an agreement to acquire 100% stake in NewRise Healthcare from Panacea BiotecAccording to Narayana Hrudayalaya’s BSE filing the hospita

Read more

Electrolab to distribute Simulations Plus’ drug discovery and simulation software channel in India

2017-04-24 09:30:32

Simulations Plus has signed a distributor agreement in India with Electrolab IndiaBY TEAM ABLESimulations Plus, the NASDAQ-listed provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, has signed a distributor agreement in India with Electrolab India.John DiBella, Vice President for marketing and sales of Simulations Pl

Read more

India develops National Action Plan to combat Antimicrobial Resistance

2017-04-21 05:59:25

Union Minister Mr J P Nadda stressed upon the need to tackle antimicrobial resistance, which is a serious threat to global public health and that requires action across all government sectorsBy Team ABLE“Antimicrobial resistance is a serious threat to global public health that requires action across all government sectors and society and is driven by many interconnected factors. Single, isolated

Read more

Bharat Biotech to commence Phase I clinical trial of Zika vaccine next month

2017-04-20 09:53:00

Bharat Biotech International has announced that the company will initiate the Phase I clinical trial of its Zika virus vaccineBy Team ABLEHyderabad-headquartered Bharat Biotech International has announced that the company will initiate the Phase I clinical trial of its Zika virus vaccine (MR 766) in two centres in India next month.Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech i

Read more

Piramal Enterprises partners with Indian Pharmaceutical Association to educate stakeholders on responsible self-care

2017-04-20 09:51:47

The initiative has been undertaken to provide educational information and spread awareness to pharmacists and the public on responsible self-careBy Team ABLEPiramal Enterprises’ Consumer Products business has partnered with the Indian Pharmaceutical Association (IPA) to promote responsible self-care to over 5,000 chemists in India, starting in the Eastern region. In line with Piramal Group’s v

Read more

USDA commits $9.6 million towards growth of Bioeconomy in the country

2017-04-19 08:34:41

The US Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) has announced $9.6 million in available funding for projects to support the development of new bio-based products and biomaterialsBy Team ABLEThe US Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) has announced $9.6 million in available funding for projects to suppor

Read more

Indian Institute of Technology Hyderabad inks MoU with Taiwan science parks to boost R&D exchange

2017-04-19 08:31:34

Four Taiwan institutes including two science parks signed an MoU with Indian Institute of Technology Hyderabad By Team ABLEThe Indian Institute of Technology Hyderabad (IITH) has signed a Memorandum of Understanding (MOU) with three Taiwanese research institutes, National Yunlin University of Science and Technology, Central Taiwan Science Park Bureau and The Hsinchu Science Park Bureau, to facilit

Read more

Project HOPE, Takeda organize National Consultation to highlight the need for skilled workforce to tackle Non-Communicable Diseases

2017-04-19 08:27:30

Project HOPE in association with Takeda Pharmaceutical organized a National Consultation on “Optimizing the Skills of Health Workforce to Tackle NCDs in IndiaBy Team ABLENon-communicable diseases (NCDs) account for 60% of deaths in India each year. According to a WHO report, cardiovascular diseases, cancers, respiratory diseases, and diabetes constitute 82% of all NCD deaths globally. The burden

Read more

Strand Life Sciences launches ‘STRAND LB’ – liquid biopsy for monitoring cancer

2017-04-17 10:13:25

Bangalore-based  Strand Life Sciences unveiled a liquid biopsy test, STRAND LB, to detect cancer from a blood sample for effective monitoring and treatment of the dreaded disease.\"As a minimal-invasive tool, our liquid biopsy test can precisely detect early presence of cancer or tumour, its recurrence and response to therapy, more than conventional diagnostic methods,\" said Strand Chairman

Read more